This page includes the latest FDA filings for Acer Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ACER | DUNS 192871002 |
Device Company | Device | Date |
---|---|---|
Acer Therapeutics Inc., Zevra Denmark A/S | Prescription Medication | 2024-10-04 |
Acer Therapeutics Inc., CH Chemie Uetikon GmbH, EMSL Analytical, Inc. DBA MPL Laboratories, Glatt Air Techniques Inc., Sharp Clinical Services LLC | Prescription Medication | 2023-01-18 |
Acer Therapeutics Inc., CH Chemie Uetikon GmbH, EMSL Analytical, Inc. DBA MPL Laboratories, Glatt Air Techniques Inc., Sharp Clinical Services LLC | Prescription Medication | 2023-01-11 |
ACER THERAPEUTICS INC | 2023-01-01 03:37:21 | |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
Acer Therapeutics Inc. | OLPRUVA | 2022-12-22 |
CAGE Code | 76BR6 | ACER THERAPEUTICS INC. ACER THERAPEUTICS |
S.A.M. Registration | 76BR6 [79311509] | ACER THERAPEUTICS INC. |
SEC | 0001069308 | Acer Therapeutics Inc. of DELAWARE |
SEC | 0001638234 | Acer Therapeutics Inc. of DELAWARE |